Company Filing History:
Years Active: 2003
Title: Eckard Wolf: Innovator in Cloning and Skin Disorder Treatments
Introduction
Eckard Wolf is a notable inventor based in Oberschleissheim, Germany. He has made significant contributions to the fields of cloning and medical treatments for skin disorders. With a total of 2 patents, his work has the potential to impact both agricultural and medical sectors.
Latest Patents
Eckard Wolf's latest patents include two innovative processes. The first patent focuses on "Efficient nuclear transfer using fetal fibroblasts and multiple cloning procedures." This invention relates to a method for breeding animals through cloning, specifically aimed at the reproduction of animal embryos via an efficient nucleus transfer with fetal fibroblasts. The second patent involves the "Use of polypeptides or nucleic acids for the diagnosis or treatment of skin disorders and wound healing." This method utilizes polypeptides or nucleic acids for diagnosing, preventing, and treating diseases related to skin cells and wound healing, as well as identifying pharmacologically active substances.
Career Highlights
Throughout his career, Eckard Wolf has worked with various companies, including Switch Biotech AG and Agrobiogen GmbH. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in biotechnology.
Collaborations
Eckard has collaborated with notable individuals in his field, including Sabine Werner and Jörn-Peter Halle. These partnerships have likely enhanced his research and development efforts, leading to his successful patent applications.
Conclusion
Eckard Wolf's contributions to cloning and skin disorder treatments highlight his innovative spirit and dedication to advancing science. His patents reflect a commitment to improving agricultural practices and medical treatments, showcasing the importance of innovation in addressing real-world challenges.